Effective vemurafenib monotherapy for refractory Langerhans cell histiocytosis with sustained results post-withdrawal for over two years: a case report

Authors

Ling Gu (ORCID: https://orcid.org/0000-0002-2410-1696)
Xue Tang (ORCID: https://orcid.org/0000-0002-3983-979X)
Jiaxin Ren (ORCID: https://orcid.org/0009-0009-5441-3349)

Institutions

Sichuan University (CN)
West China Second University Hospital of Sichuan University (CN)

Publication Details

Journal: Frontiers in Oncology
Published: 2025-10-09
DOI: https://doi.org/10.3389/fonc.2025.1688802
Primary Topic: Histiocytic Disorders and Treatments
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Effective vemurafenib monotherapy for refractory Langerhans cell histiocytosis with sustained results post-withdrawal for over two years: a case report

Ling Gu, Xue Tang, Jiaxin Ren

Oct 9, 2025

Frontiers in Oncology

Histiocytic Disorders and Treatments

article

Effective vemurafenib monotherapy for refractory Langerhans cell histiocytosis with sustained results post-withdrawal for over two years: a case report

Ling Gu, Xue Tang, Jiaxin Ren

October 9, 2025article en

Abstract

No abstract available for this paper.

Frontiers in OncologyVol. 15

Sichuan University (CN), West China Second University Hospital of Sichuan University (CN)

Openalex Percentile: Top 64%

Histiocytic Disorders and Treatments

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Effective vemurafenib monotherapy for refractory Langerhans cell histiocytosis with sustained results post-withdrawal for over two years: a case report — Ling Gu, Xue Tang, et al. · Frontiers in Oncology (2025) | TGRS Research Map | TGRS